This is a preview of subscription content, log in via an institution to check access.
Notes
British pounds
Medicines and Healthcare products Regulatory Agency
Reference
NICE. NICE gives green light to pembrolizumab for advanced skin cancer. Media Release : 7 Oct 2015. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE recommends pembrolizumab for advanced melanoma. PharmacoEcon Outcomes News 739, 35 (2015). https://doi.org/10.1007/s40274-015-2553-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2553-4